Geode Capital Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Buy |
183,287
+30,674
| +20% | +$66.6K | ﹤0.01% | 3629 |
|
|
2025
Q1 | $229K | Buy |
152,613
+53,049
| +53% | +$79.6K | ﹤0.01% | 3796 |
|
|
2024
Q4 | $501K | Buy |
99,564
+450
| +0.5% | +$2.27K | ﹤0.01% | 3602 |
|
|
2024
Q3 | $799K | Buy |
99,114
+22,881
| +30% | +$184K | ﹤0.01% | 3430 |
|
|
2024
Q2 | $439K | Buy |
76,233
+5,442
| +8% | +$31.4K | ﹤0.01% | 3608 |
|
|
2024
Q1 | $843K | Buy |
70,791
+2,015
| +3% | +$24K | ﹤0.01% | 3425 |
|
|
2023
Q4 | $1.29M | Buy |
68,776
+12,736
| +23% | +$238K | ﹤0.01% | 3247 |
|
|
2023
Q3 | $532K | Buy |
56,040
+4,390
| +8% | +$41.7K | ﹤0.01% | 3580 |
|
|
2023
Q2 | $738K | Hold |
51,650
| – | – | ﹤0.01% | 3472 |
|
|
2023
Q1 | $796K | Buy |
51,650
+8,092
| +19% | +$125K | ﹤0.01% | 3446 |
|
|
2022
Q4 | $584K | Buy |
43,558
+1,262
| +3% | +$16.9K | ﹤0.01% | 3592 |
|
|
2022
Q3 | $579K | Hold |
42,296
| – | – | ﹤0.01% | 3646 |
|
|
2022
Q2 | $479K | Buy |
42,296
+269
| +0.6% | +$3.05K | ﹤0.01% | 3788 |
|
|
2022
Q1 | $561K | Buy |
42,027
+1,082
| +3% | +$14.4K | ﹤0.01% | 3878 |
|
|
2021
Q4 | $719K | Hold |
40,945
| – | – | ﹤0.01% | 3868 |
|
|
2021
Q3 | $1.3M | Buy |
40,945
+2,376
| +6% | +$75.4K | ﹤0.01% | 3551 |
|
|
2021
Q2 | $3.3M | Buy |
38,569
+10,986
| +40% | +$940K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $769K | Buy |
+27,583
| New | +$769K | ﹤0.01% | 3663 |
|